Apolipoprotein A-I, Phospholipid Vesicles, and Cyclodextrins as Potential Anti-Atherosclerotic Drugs: Delivery, Pharmacokinetics, and Efficacy

Drug Delivery - United Kingdom
doi 10.1080/10717540050120205
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Apolipoprotein L1 Confers pH-switchable Ion Permeability to Phospholipid Vesicles

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Pharmacokinetics and Efficacy of Topically Applied Nonsteroidal Anti-Inflammatory Drugs in Retinochoroidal Tissues in Rabbits

PLoS ONE
Multidisciplinary
2014English

Membrane-Potential-Dependent Changes of the Lipid Microviscosity of Mitochondria and Phospholipid Vesicles

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1984English

Nonsteroidal Anti-Inflammatory Drugs as Potential Ecto-Nucleotide Phosphodiesterase Inhibitors

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Dissociation of Apolipoprotein E Oligomers to Monomer Is Required for High-Affinity Binding to Phospholipid Vesicles

Biochemistry
Biochemistry
2011English

Preclinical Efficacy and Pharmacokinetics of AP5346, a Novel Diaminocyclohexane-Platinum Tumor-Targeting Drug Delivery System

Clinical Cancer Research
Cancer ResearchOncology
2006English

Photosensitive Drugs: A Review on Their Photoprotection by Liposomes and Cyclodextrins

Drug Delivery
MedicinePharmaceutical Science
2017English

Comparison of Apolipoprotein B and Low Density Lipoprotein Cholesterol as Atherosclerotic Cardiovascular Risk Factors

American Society for Clinical Laboratory Science
2019English

Electrical Properties of Phospholipid Vesicles

Biophysical Journal
Biophysics
1970English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy